Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Explore the novel findings of a phase 2 trial on the tri-agonist retatrutide, demonstrating substantial weight reductions in adults with obesity over a 48-week period.
Endocrinology, Diabetes, Metabolism July 5th 2023
Annals of Internal Medicine
The study offers interesting insights into methods for controlling weight by examining the effects of time-restricted eating and calorie restriction. Physicians who are curious about the most recent weight loss techniques and their varying efficacy levels should read this study.
Internal Medicine July 5th 2023
MDLinx
Explore the benefits of time-restricted eating, a diet pattern that suggests fewer, regular meals and fasting periods could improve insulin resistance, brain health, and glycemic control, potentially reducing the risk of developing type 2 diabetes and obesity.
Endocrinology, Diabetes, Metabolism June 29th 2023
Explore how orforglipron, a novel nonpeptide GLP-1 receptor agonist, promises a significant advance in obesity treatment, achieving a weight reduction of at least 10% in nearly half to three-quarters of trial participants.
Internal Medicine June 28th 2023
ACP Internist
Dive into this fascinating clinical case of a 70-year-old patient with persistent diarrhea and weight loss, and help decipher the most appropriate management strategy in light of his unique clinical picture.
Internal Medicine June 22nd 2023
ReachMD
Explore the fascinating field of obesity management, where pharmacological treatments are combined with lifestyle modifications, to find out how doctors are reversing the trend in the fight against this epidemic on a global scale.
Endocrinology, Diabetes, Metabolism June 21st 2023